Evaluation of ventoclax initiation prophylaxis and monitoring outcomes at each dose level and time point in patients with chronic lymphocytic leukemia: A real-world experience
Authors
Frederick Lansigan (ORCID: https://orcid.org/0000-0001-6027-3359)
Evaluation of ventoclax initiation prophylaxis and monitoring outcomes at each dose level and time point in patients with chronic lymphocytic leukemia: A real-world experience
Frederick Lansigan, Isabelle Fleury, Andrés Chang, Laurie K. Pearson et al.
Journal
Blood
Topics
Chronic Lymphocytic Leukemia Research
article
Evaluation of ventoclax initiation prophylaxis and monitoring outcomes at each dose level and time point in patients with chronic lymphocytic leukemia: A real-world experience
Frederick Lansigan, Isabelle Fleury, Andrés Chang, Laurie K. Pearson, Brian T. Hill, Michael Coyle, Lori Ann Leslie, Nicole Lamanna, Alan P Skarbnik, Jennifer R. Brown, Wendy Sinai, Deborah Marie Stephens, Nnadozie Emechebe, Nicolás Martínez‐Calle, Lindsey E. Roeker, Mazyar Shadman, Toby A. Eyre, Irina Pivneva, Joanna Meehan Rhodes, Annie Guerin, Matthew Steven Davids, Meghan C. Thompson, Hande H. Tuncer, Beenish S. Manzoor, Christopher E. Jensen, Talissa Watson, Nilanjan Ghosh, Chaitra S. Ujjani, Samin Houshyar, Bita Fakhri, Robson Lima, Cui Zhu, Paul Barr
article en
Abstract
No abstract available for this paper.
Publication Tag
BloodVol. 146(Supplement 1)
Institutions
Rutgers, The State University of New Jersey (US), University of North Carolina at Chapel Hill (US), Dartmouth–Hitchcock Medical Center (US), Tufts Medical Center (US), Toyota Motor Corporation (Switzerland) (CH), Cleveland Clinic (US), Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa (ZA), Nottingham University Hospitals NHS Trust (GB), Memorial Sloan Kettering Cancer Center (US), Emory University (US), University of Massachusetts Chan Medical School (US), Churchill Hospital (GB), Lowell General Hospital (US), Novant Health (US), University of Rochester Medical Center (US), Hôpital Maisonneuve-Rosemont (CA), AbbVie (United States) (US), University of Oxford (GB), Fred Hutch Cancer Center (US), Schlumberger (United States) (US), Levine Cancer Institute (US), Dana-Farber Cancer Institute (US), Group for Research in Decision Analysis (CA), Hackensack Meridian Health (US), University of Worcester (GB), Stanford University (US)